Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 23.00 |
| 開市 | 23.00 |
| 買盤 | 22.43 x 100 |
| 賣出價 | 22.52 x 300 |
| 今日波幅 | 22.05 - 23.28 |
| 52 週波幅 | 20.84 - 34.28 |
| 成交量 | |
| 平均成交量 | 1,179,224 |
| 市值 | 2.334B |
| Beta 值 (5 年，每月) | 0.48 |
| 市盈率 (最近 12 個月) | 23.91 |
| 每股盈利 (最近 12 個月) | 0.94 |
| 業績公佈日 | 2024年5月01日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 42.73 |
ZacksCorcept (CORT) Posts Positive Data From Cushing's Syndrome Study
Corcept (CORT) reports positive data from the open-label portion of the phase III GRACE study evaluating relacorilant for treating patients with Cushing's syndrome.
ZacksCorcept (CORT) Upgraded to Strong Buy: Here's What You Should Know
Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ZacksCorcept (CORT) Completes Enrollment in Phase II ALS Study
The phase II DAZALS study is evaluating Corcept's (CORT) dazucorilant for treating patients with amyotrophic lateral sclerosis. Enrollment in the study is already complete.
